mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
0.9 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
1 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0019 |
1 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
1 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0017 |
1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0014 |
1 |